RESEARCH
16 Jan 2026
After late-stage failures, mRNA leaders narrow pipelines, double down on vaccines and cancer, and adopt tougher capital discipline
MARKET TRENDS
5 Feb 2026
PARTNERSHIPS
20 Jan 2026
INSIGHTS
13 Apr 2026
10 Apr 2026
REGULATORY
9 Apr 2026
INNOVATION
8 Apr 2026
7 Apr 2026
BioNTech co-founders will leave by year-end to launch a new next-gen mRNA company, with BioNTech taking a minority stake
2 Jun 2025
Myeloid's in-body mRNA tech aims to make cancer treatment faster, cheaper, and more widely available.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.